Â鶹ŮÓÅ

Federal health officials published a report on Thursday declaring that the use of hormonal and surgical treatments in young people with gender dysphoria lacked scientific evidence and expressing concern about long-term harms, a stark reversal from previous agency recommendations and the advice of top U.S. medical groups. The report instead prioritized the role of psychotherapy, a divisive intervention to treat gender dysphoria that many advocates and physicians have equated with so-called conversion therapy. (Ghorayshi and Harmon, 5/1)

The Trump administration is subverting the traditional priorities of the department’s decimated civil rights office by making discrimination investigations practically impossible — instead enforcing its own anti-diversity campaign. (Richards and Cohen, 5/2)

Ohio can continue to ban gender-affirming care for transgender minors while a legal fight plays out, the Ohio Supreme Court ruled April 29. House Bill 68 prevents doctors from prescribing hormones, puberty blockers or gender reassignment surgery before patients turn 18. The American Civil Liberties Union filed a lawsuit on behalf of two transgender girls and their families, contending it violates the right of transgender Ohioans to choose their health care. (BeMiller, 4/29)